🇮🇳IN
Sign In
SU

SUNPHARMA

NSE

Sun Pharmaceutical Industries Limited

₹1,761.00

+3.50(+0.20%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹2,114 Crnet foreign buying
2026-09-01 to 2026-09-15

This is the flow into the whole Healthcare sector, not into SUNPHARMA. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

SUNPHARMA exposure summary

Sun Pharmaceutical Industries Limited reports a single business segment, Pharmaceuticals. Sun Pharmaceutical Industries Limited is a constituent of 12 indices, with its largest weights in NIFTY Pharma (19.51%), NIFTY Healthcare Index (16.94%), NIFTY India Manufacturing (3.92%). It is part of the Sun Pharma Group business group. 31 exchange-traded funds hold the stock.

Index memberships12
ETFs holding31
Business groupSun Pharma Group

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer